{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Orlando",
      "state": "FL",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "89717",
      "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy",
      "address_1": "6700 Conroy Rd Ste 155",
      "address_2": "N/A",
      "postal_code": "32835-3515",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA including Puerto Rico.",
      "recall_number": "D-0720-2022",
      "product_description": "Formula F9, Papaverine 0.9 mg/mL, Phentolamine 0.1 mg/mL, PGE 20 mcg/mL, Atropine 0.01 mg/mL, Multi-Dose 10 mL vial, Each ML contains: 0.5% Chlorobutanol NF, 0.005% Edetate Disodium Dihydrate USP, 2.74% Benzyl Alcohol NF, 5% Mannitol USP, 1% Sodium Metabisulfite NF, 1% Ethyl Alcohol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0004-10",
      "product_quantity": "493 vials.",
      "reason_for_recall": "Sub Potent",
      "recall_initiation_date": "20220308",
      "center_classification_date": "20220329",
      "termination_date": "20231004",
      "report_date": "20220330",
      "code_info": "Lot: D41C19 Exp. 4/19/22"
    }
  ]
}